Resonance Specialtie
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Resonance Specialties' board approved the purchase of a manufacturing facility at Mandideep, Madhya Pradesh, from promoter-group company Kaygee Laboratories for ₹29.98 crore on a slump sale basis, subject to shareholder approval. The unit, comprising around 22,304 sq m of leasehold land and 5,227 sq m of buildings with plant and machinery, supplies chemical intermediates and APIs to Resonance on an exclusive job-work basis. The company described the transaction as an arm's length related-party deal backed by an independent registered valuer. In the June quarter, Resonance reported net profit of ₹5.74 crore on revenue of ₹32.58 crore, up from ₹1.63 crore and ₹21.27 crore a year earlier.
Powered by Tijori
Resonance Specialties' board approved the purchase of a manufacturing facility at Mandideep, Madhya Pradesh, from promoter-group company Kaygee Laboratories for ₹29.98 crore on a slump sale basis, subject to shareholder approval. The unit, comprising around 22,304 sq m of leasehold land and 5,227 sq m of buildings with plant and machinery, supplies chemical intermediates and APIs to Resonance on an exclusive job-work basis. The company described the transaction as an arm's length related-party deal backed by an independent registered valuer. In the June quarter, Resonance reported net profit of ₹5.74 crore on revenue of ₹32.58 crore, up from ₹1.63 crore and ₹21.27 crore a year earlier.
Powered by Tijori
May 14 (Reuters) - Resonance Specialties Ltd RESP.BO:
RESONANCE SPECIALTIES LTD - RECOMMENDS DIVIDEND OF 1 RUPEE PER SHARE
Source text: ID:nBSE9qWGdc
Further company coverage: RESP.BO
(([email protected];))
May 14 (Reuters) - Resonance Specialties Ltd RESP.BO:
RESONANCE SPECIALTIES LTD - RECOMMENDS DIVIDEND OF 1 RUPEE PER SHARE
Source text: ID:nBSE9qWGdc
Further company coverage: RESP.BO
(([email protected];))
May 11 (Reuters) - Resonance Specialties Ltd RESP.BO:
DIVIDEND OF 1 RUPEE PER SHARE
Source text for Eikon: ID:nBSE94QPsr
Further company coverage: RESP.BO
(([email protected];))
May 11 (Reuters) - Resonance Specialties Ltd RESP.BO:
DIVIDEND OF 1 RUPEE PER SHARE
Source text for Eikon: ID:nBSE94QPsr
Further company coverage: RESP.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Resonance Specialtie do?
Resonance Specialties, operating since 1989, is a leader in Pyridine chemistry, manufacturing products like Pyridine, Picoline, and derivatives. Their ISO certified plant in India adheres to GMP guidelines, ensuring top-quality production.
Who are the competitors of Resonance Specialtie?
Resonance Specialtie major competitors are Par Drugs & Chem., Kanchi Karpooram, Multibase India, IVP, Cochin Minerals&Rut., Archit Organosys, Hind Organic Chem. Market Cap of Resonance Specialtie is ₹193 Crs. While the median market cap of its peers are ₹222 Crs.
Is Resonance Specialtie financially stable compared to its competitors?
Resonance Specialtie seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Resonance Specialtie pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Resonance Specialtie latest dividend payout ratio is 11.1% and 3yr average dividend payout ratio is 14.34%
How has Resonance Specialtie allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory
How strong is Resonance Specialtie balance sheet?
Balance sheet of Resonance Specialtie is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Resonance Specialtie improving?
Yes, profit is increasing. The profit of Resonance Specialtie is ₹14.51 Crs for TTM, ₹10.4 Crs for Mar 2026 and ₹6.57 Crs for Mar 2025.
Is the debt of Resonance Specialtie increasing or decreasing?
The net debt of Resonance Specialtie is decreasing. Latest net debt of Resonance Specialtie is ₹0.86 Crs as of Mar-26. This is less than Mar-25 when it was ₹1.88 Crs.
Is Resonance Specialtie stock expensive?
Resonance Specialtie is not expensive. Latest PE of Resonance Specialtie is 13.31, while 3 year average PE is 22.22. Also latest EV/EBITDA of Resonance Specialtie is 10.28 while 3yr average is 15.07.
Has the share price of Resonance Specialtie grown faster than its competition?
Resonance Specialtie has given better returns compared to its competitors. Resonance Specialtie has grown at ~27.67% over the last 7yrs while peers have grown at a median rate of 15.92%
Is the promoter bullish about Resonance Specialtie?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Resonance Specialtie is 54.25% and last quarter promoter holding is 54.25%.
Are mutual funds buying/selling Resonance Specialtie?
There is Insufficient data to gauge this.